deltatrials
Unknown OBSERVATIONAL NCT05309408

A Longitudinal Analysis of Biomarkers in Patients With ALS (LAB-PALS)

Sponsor: Holy Cross Hospital, Florida

Conditions Amyotrophic Lateral Sclerosis
Interventions Lumbar Puncture Venipuncture
Updated 5 times since 2022 Last updated: Sep 21, 2023 Started: Jun 11, 2021 Primary completion: Sep 30, 2024 Completion: Sep 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05309408, this observational or N/A phase trial focuses on Amyotrophic Lateral Sclerosis and remains ongoing. Sponsored by Holy Cross Hospital, Florida, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2022 – ~Oct 2023 · 17 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotRecruiting~Oct 2025 – present · 9 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Oct 2025 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2024 — Oct 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Oct 2023 — Jul 2024 [monthly]

    Recruiting

  5. May 2022 — Oct 2023 [monthly]

    Recruiting

    First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Holy Cross Hospital, Florida
  • Massachusetts General Hospital
Data source: Holy Cross Hospital, Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations